Optimized microRNA purification from TRIzol-treated plasma

BMC Genomics

Volumn 16, Issue 1, 2015, Pages

  Duy, Janice ^a   Koehler, Jeffrey W ^a   Honko, Anna N ^b,c   Minogue, Timothy D ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c US Army Medical Institute of Infectious Diseases   (United States)

Author keywords

Biomarker; Ebola virus; microRNA; Nonhuman primate; Plasma; RNA extraction; RT PCR; TRIzol

Indexed keywords

GLYCOGEN; MICRORNA; PHENOL DERIVATIVE; TRIZOL; UNCLASSIFIED DRUG; GUANIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CONTROLLED STUDY; DOWN REGULATION; EBOLA HEMORRHAGIC FEVER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; NONHUMAN; PHASE SEPARATION; PLASMA; PROCESS OPTIMIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; RNA EXTRACTION; RNA PURIFICATION; RNA SEQUENCE; UPREGULATION; VIRUS VIRULENCE; ANIMAL; BLOOD; EBOLAVIRUS; GENETICS; ISOLATION AND PURIFICATION; VIROLOGY;

EBOLA VIRUS; MACACA MULATTA; PRIMATES;

ANIMALS; EBOLAVIRUS; GUANIDINES; HEMORRHAGIC FEVER, EBOLA; MACACA MULATTA; MICRORNAS; PHENOLS;

EID: 84924326113     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-015-1299-5     Document Type: Article

References (44)

1. Haider BA, Baras AS, McCall MN, Hertel JA, Cornish TC, Halushka MK. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One. 2014;9:e89565.
2. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733-41.
3. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223-33.
4. Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012;37:460-5.
5. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2011;80:193-208.
6. Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18:371-90.
7. Pritchard C, Cheng H, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13:358-69.
8. Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013;8:e64795.
9. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011;6:e24145.
10. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011;57:833-40.
11. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res. 2012;5:492-7.
12. Shurtleff A, Garza N, Lackemeyer M, Carrion R, Griffiths A, Patterson J, et al. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment. Viruses. 2012;4:3932-51.
13. Blow JA, Dohm DJ, Negley DL, Mores CN. Virus inactivation by nucleic acid extraction reagents. J Virol Methods. 2004;119:195-8.
14. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3:e3694.
15. Kim DJ, Linnstaedt S, Palma J, Park JC, Ntrivalas E, Kwak-Kim JY, et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn. 2012;14:71-80.
16. McAlexander MA, Phillips MJ, Witwer KW. Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid. Front Genet. 2013; 4:83.
17. Kim Y-K, Yeo J, Kim B, Ha M, Kim VN. Short structured RNAs with Low GC content Are selectively lost during extraction from a small number of cells. Mol Cell. 2012;46:893-5.
18. Kirschner M, van Zandwijk N, Reid G. Cell-free microRNAs: potential biomarkers in need of standardized reporting. Front Genet. 2013;4:56.
19. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One. 2011;6:e20769.
20. Redshaw N, Wilkes T, Whale A, Cowen S, Huggett J, Foy CA. A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability. Biotechniques. 2013;54:155-64.
21. Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59:2.
22. Plé H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS One. 2012;7:e50746.
23. Alexandrov A, Dutta K, Pascal SM. Sensitive ribonuclease protection assay employing glycogen as a carrier and single inactivation/precipitation step. Biotechniques. 2001;30:1198-204.
24. Gaillard C, Strauss F. Ethanol precipitation of DNA with linear polyacrylamide as carrier. Nucleic Acids Res. 1990;18:378.
25. Brameier M. Genome-wide comparative analysis of microRNAs in three non-human primates. BMC Res Notes. 2010;3:64.
26. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci. 2008;105:10513-8.
27. Wang K, Yuan Y, Cho J, McClarty S, Baxter D, Galas D. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012;7:e41561.
28. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003-8.
29. García ME, Blanco JL, Caballero J, Gargallo-Viola D. Anticoagulants interfere with PCR used to diagnose invasive Aspergillosis. J Clin Microbiol. 2002;40:1567-8.
30. Willems M, Moshage H, Nevens F, Fevery J, Yap SH. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J Virol Methods. 1993;42:127-30.
31. Cui W, Ma J, Wang Y, Biswal S. Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One. 2011;6:e22988.
32. Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res. 2008;8:113-7.
33. Andreasen D, Fog JU, Biggs W, Salomon J, Dahslveen IK, Baker A, et al. Improved microRNA quantification in total RNA from clinical samples. Methods. 2010;50:S6-9.
34. Turchinovich A, Weiz L, Burwinkel B. Isolation of circulating MicroRNA associated with RNA-binding protein. In: Kosaka N, editor. Circulating MicroRNAs, vol. 1024. New York: Humana Press; 2013. p. 97-107. Methods in Molecular Biology.
35. Page K, Guttery DS, Zahra N, Primrose L, Elshaw SR, Pringle JH, et al. Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One. 2013;8:e77963.
36. Sourvinou IS, Markou A, Lianidou ES. Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Mol Diagn. 2013;15:827-34.
37. Twenhafel NA, Mattix ME, Johnson JC, Robinson CG, Pratt WD, Cashman KA, et al. Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques. Vet Pathol. 2013;50:514-29.
38. Jensen S, Lamy P, Rasmussen M, Ostenfeld M, Dyrskjot L, Orntoft T, et al. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics. 2011;12:435.
39. Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11:809-15.
40. Monleau M, Bonnel S, Gostan T, Blanchard D, Courgnaud V, Lecellier C-H. Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells. BMC Genomics. 2014;15:395.
41. National Research Council. Guide for the care and use of laboratory animals. 8th ed. Washington, D.C: The National Academies Press; 2011.
42. R Core Team. R: A language and environment for statistical computing. In Book R: A language and environment for statistical computing (Editor ed.^eds.). City: R Foundation for Statistical Computing. 2014.
43. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8.
44. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009;10:R64.